COVID-19 Detection Kits Market Size By Product (RT-PCR Assay Kits, Immunoassay Test Strips/Cassettes), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab), By End-use (Hospitals, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Sep 2020  |  Report ID: GMI4610  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 163   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

COVID-19 Detection Kits Market size valued at USD 15.4 billion in 2020 and is expected to witness -2.8% CAGR from 2020 to 2026.
 

The novel strain, acute respiratory syndrome coronavirus 2 (SARS-COV-2), has affected the lives of millions of people across the globe. According to the ECDC, as of 16th September, there were around 29 million confirmed cases universally. Rapid outburst of COVID-19 due to lack of social distancing in some countries and rising number of COVID-19 affected patients will augment the market growth.
 

COVID-19 Detection Kits Market
Get more details on this report - Request Free Sample PDF
 

The vigorous spread of the disease has set an alarm for healthcare providers creating necessity for COVID-19 detection kits. Therefore, medical device manufacturers have surged the production of COVID-19 detection kits for testing of maximum number of affected individuals. Also, rising need for effective COVID-19 detection testing solutions for high-risk population base including geriatric and people with weak immune system will impel the industry growth.
 

COVID-19 Detection Kits Market Report Coverage
Report Coverage Details
Base Year: 2020 Market Size in 2020: 15.4 Billion (USD)
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: -2.3% 2026 Value Projection: 13.0 Billion (USD)
Pages: 163 Tables, Charts & Figures: 216
Geographies covered (39): U.S., Canada, Germany, UK, France, Italy, Spain, Austria, Portugal, Israel, Sweden, Norway, Russia, Denmark, Poland, Switzerland, Turkey, Belgium, Netherlands Japan, China, India, Australia, South Korea, Malaysia, Philippines, Indonesia, Thailand, Singapore, Brazil, Chile, Peru, Mexico, South Africa, Iran, Israel, UAE, Qatar, Iraq
Segments covered: Product, Specimen Type, End-use and Region
Companies covered (17): Abbott Laboratories, BGI, BioMérieux (BioFire Diagnostics), Bio-Rad Laboratories, Cepheid (Danaher Corporation), Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, GenMark Diagnostics Inc., Guangzhou Wondfo Biotech Co. Ltd, Mylab Discovery Solutions Pvt. Ltd, Qiagen, Quidel Corporation, Randox Laboratories Ltd, SD Biosensor, INC, Seegene Inc, Shenzhen Bioeasy, Thermo Fisher Scientific
Growth Drivers:
  • Rising incidences of COVID-19 globally
  • High risk of infection in geriatric population
  • Increasing technological advancements in virus detection
  • Increasing government and industry players initiatives
Pitfalls & Challenges:
  • Lower accuracy of immunoassay-based tests

Get more details on this report - Request Free Sample PDF
 

Increasing government and industry players initiatives will fuel the market expansion

The COVID-19 detection kits demand has increased tremendously owing to rising number of unprecedented outbursts of infection worldwide. The COVID-19 detection kits manufacturers have increased their production to cater the soaring demand. The prominent companies are implementing various strategies to capture higher market share and withstand industry competition. For instance, in March 2020, Danaher announced the FDA approval for its COVID-19 detection test. This helped the company serve a large customer base and to sustain the market competition. Moreover, government of various affected countries have taken several action plans and measures such as surveillance testing in suspected communities.
 

Surging demand for RT-PCR kits will boost the COVID-19 detection kits market revenue

The RT-PCR assay kits segment size was around USD 11 billion in 2020. Reverse transcriptase PCR has numerous benefits including easier automation, post amplification handling, processing of large numbers of samples and higher specificity proves beneficial for the market progression. Usually, advanced RT-PCR are expensive, which curbs its availability in low income countries.
 

Increased accuracy of nasopharyngeal swab will propel the market growth

Global COVID-19 Detection Kits Market

Get more details on this report - Request Free Sample PDF
 

The nasopharyngeal swab segment accounted for more than 40% COVID-19 detection kits market share in 2020. Nasopharyngeal swab has significantly higher COVID-19 detection rate and sensitivity compared to other segment type, surging its preference. Since, the COVID-19 is a respiratory disease, most of the tests require nasopharyngeal swab for its high yield as well as specificity.
 

Surging number of COVID-19 cases will drive the hospitals segment demand

The hospitals end-use segment will register around -5.0% growth rate during the forecast period. Availability of well-developed infrastructure coupled with emergency care facilities in the hospital settings will increase its preference. Usage of COVID-19 detection kits for the diagnosis, treatment and follow up of virus is fuelling the segment growth. In addition, rising incidence of COVID-19 cases will result into surging number of hospital admissions for better treatment, boosting the market size expansion.
 

Presence of prominent market players in the European region proves valuable for the industry growth

Europe COVID-19 Detection Kits Market

Get more details on this report - Request Free Sample PDF
 

Europe COVID-19 detection kits market held over 26% revenue share in 2020. The outbreak of COVID-19 in several countries such as Russia, UK and others will fuel the European market demand. Presence of market leaders along with well-established infrastructure as well as healthcare facilities will drive the regional market growth. Also, European regulatory forms are easing out the guidelines that were made on the COVID-19 detection kits to provide faster access to these kits. Numerous COVID-19 detection kits have received CE-mark to fastrack the testing procedures in European region. Considering the current scenario, numerous manufacturers have flourished the European market with several detection kits.
 

Strategic initiatives undertaken by key market players have helped them to maintain their financial stability

Some of the leading players operating in the market include BGI, Abbott Laboratories, F. Hoffmann-La Roche, Guangzhou Wondfo Biotech, Qiagen, Seegene, Shenzhen Bioeasy Biotechnology, Co-Diagnostics, Thermo Fisher Scientific, BGI, BioFire Diagnostics among others. These market leaders have undertaken various organic and inorganic growth strategies to maintain strong foothold in the industry.
 

Recent Industry Developments:

  • In March 2020, Roche announced the U.S. FDA approval for its cobas SARS-CoV-2 test. This will enable the company to cater to the growing demand for COVID-19 detection tests, thereby securing its position in COVID-19 detection kits business
     
  • In April 2020, Co-Diagnostics Inc. announced the Emergency Use authorization for their COVID-19 detection kit. This strategy will enable to provide market penetration opportunities to the firm

The COVID-19 detection kits market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Market, By Product

  • RT-PCR assay kits
  • Immunoassay test strips/cassettes

Market, By Specimen Type

  • Nasopharyngeal swab
  • Oropharyngeal swab
  • Nasal swab
  • Others

Market, By End-use

  • Hospitals
  • Diagnostic centers
  • Others

The above information is provided for the following geographies:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Austria
    • Portugal
    • Israel
    • Sweden
    • Norway
    • Russia
    • Denmark
    • Poland
    • Switzerland
    • Turkey
    • Belgium
    • Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Malaysia
    • Philippines
    • Indonesia
    • Thailand
    • Singapore
  • Latin America
    • Brazil
    • Chile
    • Peru
    • Mexico 
  • Middle East
    • South Africa
    • Iran
    • Israel
    • UAE
    • Qatar
    • Iraq

 

Frequently Asked Questions (FAQ) :

In 2020, the market size for COVID-19 Detection Kits was USD 15.4 billion. The industry may witness -2.8% CAGR through 2026.
Due to a higher COVID-19 detection rate and sensitivity than other specimen types, the nasopharyngeal swab segment accounted for over 40% market share in 2020.
In 2020, the Europe market accounted for more than 26% revenue share. The presence of industry pioneers, well-established infrastructure, and healthcare facilities will contribute to the market growth in the region.
The hospital segment is expected to witness about -5.0% growth rate through 2026. The rise in the use of COVID-19 detection kits for diagnosis, treatment and follow up is stimulating the market growth.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Sep 2020
  • Pages: 163
  • Tables: 206
  • Charts / Figures: 10
  • Companies covered: 17
  • Countries covered: 39

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X